0001371796-20-000002.txt : 20200212 0001371796-20-000002.hdr.sgml : 20200212 20200212140118 ACCESSION NUMBER: 0001371796-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200212 DATE AS OF CHANGE: 20200212 EFFECTIVENESS DATE: 20200212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solace Therapeutics Inc CENTRAL INDEX KEY: 0001371796 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-360376 FILM NUMBER: 20603204 BUSINESS ADDRESS: STREET 1: 135 NEWBURY STREET CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 508-283-1200 MAIL ADDRESS: STREET 1: 135 NEWBURY STREET CITY: FRAMINGHAM STATE: MA ZIP: 01701 D 1 primary_doc.xml X0708 D LIVE 0001371796 Solace Therapeutics Inc 135 NEWBURY STREET FRAMINGHAM MA MASSACHUSETTS 01701 508-283-1200 DELAWARE None None Corporation true William H. Gruber 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Executive Officer Director Kevin G. Connors 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Director Brian R. Smith 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Director Gerrit Adams 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Director John McDonough 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Director Other Health Care Decline to Disclose 06b false 2020-01-30 false true false 0 17550000 4002367 13547633 false 5 0 0 0 false Solace Therapeutics Inc William H. Gruber William H. Gruber Chief Executive Officer 2020-02-12